uniQure N.V.

QURE Healthcare Biotechnology

uniQure N.V.’s revenue for fiscal 2025 (year ended December 2025) was $16.1 million, down 40.6% from fiscal 2024.

Revenue
+40.4%
EPS
+36.5%
Free cash flow
+27.7%
Total debt
−2.96%

Quarter to September 2026, against a year earlier

21.62 0.61 +2.90%
Market cap
$1.5B
P/E
0.0×
Fwd P/E
−6.6×
Dividend yield
—
F-score
5/9
Altman Z
−0.80
Beneish M
−2.95
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
655.99 390.29 651.85 476.77 628.24 258.91 384.21 236.58 162.78 143.95
Total non-current assets
168.92 166.25 179.84 228.19 180.94 81.48 64.42 37.33 46.86 46.32
Total Assets
824.91 556.54 831.69 704.96 809.18 340.40 448.63 273.91 209.64 190.27
Total current liabilities
62.92 40.05 73.68 75.92 36.76 27.33 31.63 19.97 19.23 22.72
Total non-current liabilities
563.09 523.24 550.34 153.04 176.64 69.16 93.94 74.33 101.06 103.91
Total liabilities
626.01 563.29 624.02 228.96 213.40 96.49 125.57 94.30 120.29 126.63
Common Equity (Total)
198.90 (6.75) 207.67 476.01 595.78 243.91 323.06 179.61 89.36 63.63
Shareholders Equity (Total)
198.90 (6.75) 207.67 476.01 595.78 243.91 323.06 179.61 89.36 63.63
Total Debt
49.70 51.32 101.75 102.79 100.96 35.62 36.06 43.70 20.79 20.24

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 6 Nov 2026